This national policy on Traditional, Complementary and Alternative Medicine is for the integration of conventional medicine to achieve the government’s vision of universal health coverage. It outlines the framework, laws and legislation, quality control, regulation, registration, supply chain development, monitoring and evaluation among other necessary elements to ensure the smooth running of the process.

This policy seeks to improve the provision and access to safe and quality medications for the Rwandan people.

The government of Rwanda recognises the prevalence of mental health disorders arising from the 1994 genocide in Rwanda against the Tutsis. These disorders include epilepsy, and post-traumatic stress disorders (PTSD) among others. It pursues improvement in access to health care facilities at the community level as a means of effective control of mental health issues in the country. It discusses the challenges faced in delivering effective healthcare and the need to continuously train mental health care providers and handlers.

“Highlights of the instructions of the city of Kigali council relating to hygiene in the city. The instructions seek to; Promote hygiene and sanitation in the City of Kigali, set up fundamental principles relating to hygiene protection in all ways, promote the social welfare of the population of the City of Kigali taking into account the promotion of hygiene and prevention of diseases caused by poor hygiene, and sensitise the residents of the City of Kigali on hygiene-based sustainable development”.

The law establishes the Rwanda food and medicines authority (RFMA). It determines its mission, organization, and functioning. The authority enjoys financial and administrative autonomy, as well as legal personality. The RFMA is charged with quality control and standardisation concerning food and pharmaceutical products.

The law establishes the Rwanda food and drugs authority and determines its mission, organization, and functioning. The law regulates among others; human and veterinary drugs and vaccines, herbal medicines, medicated cosmetics, tobacco and tobacco products, and laboratory and cleaning chemicals and pesticides.

To address the weak supply chain in Nigeria’s pharmaceutical industry, the Nigerian government developed the National Supply Chia Policy to guide the coordination of supply systems and drive collaboration among supply chain players to build a more developed and efficient supply chain system in Nigeria.

This policy on family planning aims to address the various challenges inhibiting the full implementation and success of family planning in Rwanda.

National Family Planning Blueprint (Scale-up Plan) highlights Nigeria’s plan for the adoption of family planning contraceptives in Nigeria. This blueprint also focuses on the processes to close the funding gap in family planning as Nigeria seeks to achieve a 36 per cent contraceptive prevalence rate by 2018. The development of this policy builds on the 2012 London Family Planning Summit.

This policy was developed to limit the spread and impact of the HIV/AIDs epidemic in the country so that it is no longer a concern of public health and socioeconomic life. The policy has two main strategies: (a) the prevention of HIV/AIDs transmission; and (b) laws and ethics to ensure the protection of rights of Nigerians, especially those living with HIV/AIDs.

This policy highlights Nigeria’s plan to improve the effectiveness of its medical emergency response system to better address emergencies and also reform the processes of attending to patients by health providers. Through this plan, Nigeria highlights the emergency medical service pathways and the roles of all stakeholders involved along the value chain.

The objective of the policy was to provide adequate, affordable and sustainable sanitation to all Nigerians through a collaborative effort of federal, state, and local government, private sector, communities, and individuals. The main strategy of the policy is the establishment of a sanitation task group with representation across the ministry of health, water resources, environment and national planning.

This policy provides guidelines to the government. Employers and employees to protect the right and dignity of workers infected and affected by HIV/AIDs; to protect workers from HIV/AIDs including mitigating the impact of HIV/AIDs in the workplace and the elimination of stigma and discrimination of those affected by HIV/AIDs.

This policy sets the quality assurance process for pharmaceutical products from the stage of design through production, procurement, storage, distribution, and marketing. It targets players in the manufacturing procurement, and supply value chains of the private sector. It aligns with the National Agency for Food and Drug Administration and Control Decree of 1993.

This Act outlines the regulation for the production, distribution, and marketing of tobacco or tobacco products in Nigeria. It clearly outlines Nigeria’s position against tobacco use and tobacco’s health effects on Nigerians. It also outlines the roles of government stakeholders in managing tobacco use in the country.

The National Minimum Standards for Drug Dependence Treatment in Nigeria was developed with the objective of minimizing drug-related harm and eradicating illicit drug use. By developing this policy, the Nigerian government hopes to improve the treatment of substance use disorders in Nigeria.

The National Drug Policy of 2005 focuses on stimulating the local production of essential drugs by Nigerian pharmaceutical companies. The policy hopes to achieve adequate supply and rational use of drugs. It also emphasized the promotion of herbal remedies and the development of raw materials for local production. In addition, this document outlines the roles of the various levels of government towards implementing this policy.

The Nigerian government developed the National Guidelines for Quantification of Narcotic medicines to standardize the quantification practices of narcotic medicines used for medical and scientific procedures in Nigeria.

The National Strategic Plan For Tuberculosis Control lays out the strategies to provide Nigerians with access to preventive, diagnosis, and curative services for TB, TB/HIV and drug-resistant TB by 2020. This plan will utilize new surveys of TB cases in Nigeria. Over the next five years, Nigeria hopes to rapidly increase detection of TB in adults and children, improve its treatment, integrate HIV and TIB services, and strengthen the capacity of healthcare providers and health systems

This document outlines the guidelines required to track maternal and perinatal mortality and establish Maternal and Perinatal Deaths Surveillance Responses in Nigeria. This policy also explains the processes for training healthcare providers to improve the quality of care and reduce maternal and new-born deaths significantly.